GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 165 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $564,000 | +330.5% | 23,601 | +120.7% | 0.00% | – |
| Q4 2016 | $131,000 | +4.0% | 10,694 | +0.4% | 0.00% | – |
| Q3 2016 | $126,000 | +37.0% | 10,655 | -0.0% | 0.00% | – |
| Q2 2016 | $92,000 | +70.4% | 10,658 | +3.5% | 0.00% | – |
| Q1 2016 | $54,000 | -76.3% | 10,300 | -39.0% | 0.00% | -100.0% |
| Q2 2014 | $228,000 | +23.9% | 16,884 | -9.0% | 0.00% | 0.0% |
| Q1 2014 | $184,000 | -9.4% | 18,544 | +21.6% | 0.00% | 0.0% |
| Q4 2013 | $203,000 | +18.7% | 15,245 | +8.2% | 0.00% | 0.0% |
| Q3 2013 | $171,000 | +64.4% | 14,090 | +40.0% | 0.00% | – |
| Q2 2013 | $104,000 | – | 10,064 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,500,000 | $25,725,000 | 3.13% |
| CADIAN CAPITAL MANAGEMENT, LP | 3,830,399 | $28,153,000 | 1.28% |
| Mesirow Financial Investment Management, Inc. | 33,001 | $243,000 | 1.25% |
| Bellevue Group AG | 1,339,502 | $9,845,000 | 0.62% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 260,000 | $1,912,000 | 0.58% |
| Lyon Street Capital, LLC | 109,850 | $807,000 | 0.50% |
| Private Wealth Partners, LLC | 300,000 | $2,205,000 | 0.34% |
| Penn Capital Management Company, LLC | 455,064 | $3,345,000 | 0.25% |
| HighTower Advisors, LLC | 2,337,132 | $17,179,000 | 0.12% |
| Schonfeld Strategic Advisors LLC | 376,000 | $2,763,000 | 0.12% |